IMCR
Price:
$28.6
Market Cap:
$1.45B
Immunocore Holdings plc, a biotechnology firm established in 1999 and based in Abingdon, United Kingdom, has reached the commercial stage in its mission to create pioneering immunotherapies. The company's development pipeline addresses a range of serious conditions, including various cancers, infectious diseases, and autoimmune disorders. Its currently marketed product, KIMMTRAK, offers a treatment option for patients with uveal melanoma that is either unresectable or has metastasized. Within oncology, Immunocore is progressing IMC-C103C through early-stage (Phase I/II) dose escalation trials for several solid tumor types, notably non-small-cell lung (NSCLC), gastric, head and neck, ovarian,...[Read more]
Industry
Biotechnology
IPO Date
2021-02-05
Stock Exchange
NASDAQ
Ticker
IMCR
According to Immunocore Holdings plc’s latest financial reports and current stock price. The company's current ROE is -4.83%. This represents a change of 285.75% compared to the average of -1.25% of the last 4 quarters.
The mean historical ROE of Immunocore Holdings plc over the last ten years is -94.46%. The current -4.83% ROE has changed -94.89% with respect to the historical average. Over the past ten years (40 quarters), IMCR's ROE was at its highest in in the March 2026 quarter at 3.29%. The ROE was at its lowest in in the December 2019 quarter at -132.69%.
Average
-94.46%
Median
-25.51%
Minimum
-531.13%
Maximum
-6.93%
Discovering the peaks and valleys of Immunocore Holdings plc ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 319.55%
Maximum Annual ROE = -6.93%
Minimum Annual Increase = -310.75%
Minimum Annual ROE = -531.13%
| Year | ROE | Change |
|---|---|---|
| 2025 | -6.93% | -38.71% |
| 2024 | -11.31% | -24.53% |
| 2023 | -14.99% | 16.87% |
| 2022 | -12.83% | -77.75% |
| 2021 | -57.64% | -56.94% |
| 2020 | -133.87% | -74.79% |
| 2019 | -531.13% | 319.55% |
| 2018 | -126.60% | 251.29% |
| 2017 | -36.04% | 172.62% |
| 2016 | -13.22% | -310.75% |
The current ROE of Immunocore Holdings plc (IMCR) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-11.08%
5-year avg
-20.74%
10-year avg
-94.46%
Immunocore Holdings plc’s ROE is less than Xeris Biopharma Holdings, Inc. (735.00%), greater than Janux Therapeutics, Inc. (-11.85%), greater than Vera Therapeutics, Inc. (-74.86%), greater than Celldex Therapeutics, Inc. (-50.72%), greater than AbCellera Biologics Inc. (-14.86%), greater than Sionna Therapeutics, Inc. (-27.31%), less than Harmony Biosciences Holdings, Inc. (17.19%), greater than Biohaven Ltd. (-866.46%), less than MannKind Corporation (45.59%), greater than Nuvation Bio Inc. (-44.10%),
| Company | ROE | Market cap |
|---|---|---|
| 735.00% | $1.20B | |
| -11.85% | $867.20M | |
| -74.86% | $2.52B | |
| -50.72% | $2.16B | |
| -14.86% | $1.69B | |
| -27.31% | $1.68B | |
| 17.19% | $1.93B | |
| -866.46% | $1.44B | |
| 45.59% | $1.22B | |
| -44.10% | $1.93B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Immunocore Holdings plc using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Immunocore Holdings plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Immunocore Holdings plc's ROE?
How is the ROE calculated for Immunocore Holdings plc (IMCR)?
What is the highest ROE for Immunocore Holdings plc (IMCR)?
What is the 3-year average ROE for Immunocore Holdings plc (IMCR)?
What is the 5-year average ROE for Immunocore Holdings plc (IMCR)?
How does the current ROE for Immunocore Holdings plc (IMCR) compare to its historical average?